CONDITIONAL TRANSFER ORDER (CTO 1) - Pursuant to Rule 7.1 of the Rules of Procedure of the United States Judicial Panel on Multidistrict Litigation, the action(s) on the attached schedule are transferred under 28 U.S.C. ยง 1407 to the Northern District of Ohio for the reasons stated in the order of December 5, 2017, and, with the consent of that court, assigned to the Honorable Dan A Polster. This order does not become effective until it is filed in the Office of the Clerk of the United States District Court for the Northern District of Ohio (pb)
SUMMONS Returned Executed as to Defendants Actavis Pharma, Inc.; Actavis, LLC; Cephalon, Inc.; McKesson Corporation; Purdue Pharma, Inc.; and Teva Pharmaceuticals USA, Inc. Actavis Pharma, Inc.; Actavis, LLC; Cephalon, Inc.; McKesson Corporation; and Teva Pharmaceuticals USA, Inc. served on 11/30/2017, Answers due 12/21/2017. Purdue Pharma, Inc. served on 12/1/2017, Answer due 12/22/2017. (ew)
SUMMONS Returned Executed: Defendants AmerisourceBergen Drug Corporation, Cardinal Health, Inc., Endo Pharmaceuticals, Inc., Janssen Pharmaceutica, Inc., Watson Laboratories, Inc. served on 11/30/2017, answer due 12/21/2017; Purdue Pharma L.P. served on 12/1/2017, answer due 12/22/2017. (kpt)
RELATED CASE MEMORANDUM ORDER: The Judges agree that this case and case number 2:17-cv-662,2:17-cv-663,2:17-cv-664,2:17-cv-665,2:17-cv-680,2:17-cv-682,2:17-cv-696, 2:17-cv-704,2:17-cv-713,2:17-cv-723,2:17-cv-768,2:17-cv-769,2:17-cv-770,2:17-cv-883, 2:17-cv-886,2:17-cv-891,2:17-cv-894,2:17-cv-904,2:17-cv-918,2:17-cv-975,2:17-cv-1012 are related, the subject case nevertheless will remain with the Judge to who it was assigned. Signed by Chief Judge Edmund A. Sargus on November 30, 2017. (jlk)
Third party AI contribution in government documents
Possible
Document content is reproduced directly from government sources. Some filings in our database may themselves contain AI-generated content submitted by third parties to government agencies.
Update
Alerts
Jump
